Clinical Pharmacology & Therapeutics

OCT 9, 2026 · JOURNAL ARTICLE

Obstetric Pharmacomicrobiomics

Clinical Pharmacology & Therapeutics

Pregnancy is characterized by physiologic, metabolic, immunologic, and microbial adaptation. Medication use during pregnancy is common. Yet, therapeutic response often remains unpr

SEP 7, 2026 · JOURNAL ARTICLE

Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset

Clinical Pharmacology & Therapeutics

This is a consensus-derived core dataset specification developed through systematic literature review and multi-stakeholder expert meetings to standardize real-world data collection for NSCLC drug evaluation.

AUG 28, 2026 · JOURNAL ARTICLE

Long‐Acting Therapeutics in Pediatric Health: Bridging Innovation and Access

Clinical Pharmacology & Therapeutics

Expert consensus review synthesizing evidence and recommendations on long-acting therapeutics development for pediatric populations, addressing clinical pharmacology, safety, and implementation considerations.

AUG 17, 2026 · JOURNAL ARTICLE

Enzalutamide‐Induced Host Metabolic Reprogramming Is Associated with Treatment Outcomes in Patients with Castration‐Resistant Prostate Cancer: A Hypothesis‐Generating Study

Clinical Pharmacology & Therapeutics

A small, single-centre, uncontrolled exploratory study with mechanistic in vitro validation that raises the question of whether metabolomic signatures predict enzalutamide response, but does not yet answer it with prospective validation or clinical outcomes.

AUG 10, 2026 · JOURNAL ARTICLE

Tirzepatide Use Is Associated with Reduced Risk of Carpal Tunnel Syndrome in Overweight and Obese Adults

Clinical Pharmacology & Therapeutics

Retrospective cohort study with propensity score matching showing reduced CTS risk with tirzepatide versus comparators, but observational design, potential residual confounding, and surrogate clinical outcomes limit strength.